Postoperative nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma

被引:33
作者
Kim, Seung Hyun [1 ]
Shin, Kyoo-Ho [1 ]
Kim, Ha Yan [2 ]
Cho, Yong Jin [1 ]
Noh, Jae Kyoung
Suh, Jin-Suck [3 ,4 ,5 ]
Yang, Woo-Ick [6 ]
机构
[1] Yonsei Univ, Coll Med, Dept Orthopaed Surg, Seoul, South Korea
[2] Yonsei Univ, Coll Med, Biostat Collaborat Unit, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Ctr Canc, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Inst Radiol Sci, Seoul, South Korea
[6] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
关键词
Osteosarcoma; Metastasis; Nomogram; Dichotomous outcomes; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; NONMETASTATIC OSTEOSARCOMA; SURVIVAL; EXPERIENCE; SARCOMA; INSTITUTION; EFFICACY; RIZZOLI; JOINTS;
D O I
10.1186/1471-2407-14-666
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Metastasis is the most crucial prognostic factor in osteosarcoma. The goal of this study was to develop a new nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma after neoadjuvant chemotherapy and limb salvage surgery. Methods: We examined medical records of 91 patients who had undergone surgery between March 1994 and March 2007. A nomogram was developed using multivariate logistic regression. The nomogram was validated internally by bootstrapping-method (200 repetitions) and externally in independent validation set (n = 34). A Youden-derived cutoff value was assigned to the nomogram to predict dichotomous outcomes for metastasis. Results: The nomogram was built from four predictors of tumor site, serum alkaline phosphatase, intracapsular extension, and Huvos grade, and an additional clause that the cutoff value should be added to the total points in the cases of incomplete surgical resection. P-value of Hosmer and Lemshow Goodness-of-fit test of this model was 0.649. Area under receiver operating curve values of 0.83 (95% confidence interval [CI], 0.75 to 0.92) in the training set and 0.80 (95% CI, 0.63 to 0.96) in the validation set were obtained. The accuracy of dichotomous outcomes was 79.1% (95% CI, 0.69 to 0.86) and 82.4% (95% CI, 0.63 to 0.92) in the training and validation sets. Conclusions: We have developed a new high-performance nomogram to predict the probability of metastasis in Enneking stage IIB extremity osteosarcoma after limb salvage surgery.
引用
收藏
页数:10
相关论文
共 28 条
[1]  
BACCI G, 1993, CANCER-AM CANCER SOC, V71, P1224, DOI 10.1002/1097-0142(19930215)71:4<1224::AID-CNCR2820710409>3.0.CO
[2]  
2-M
[3]   Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution [J].
Bacci, G ;
Longhi, A ;
Versari, M ;
Mercuri, M ;
Briccoli, A ;
Picci, P .
CANCER, 2006, 106 (05) :1154-1161
[4]   Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: Experience at rizzoli on 1421 patients treated over the last 30 years [J].
Bacci, G ;
Longhi, A ;
Ferrari, S ;
Briccoll, A ;
Donati, D ;
De Paolis, M ;
Versari, M .
TUMORI, 2004, 90 (05) :478-484
[5]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790
[6]   Second and Subsequent Recurrences of Osteosarcoma: Presentation, Treatment, and Outcomes of 249 Consecutive Cooperative Osteosarcoma Study Group Patients [J].
Bielack, Stefan S. ;
Kempf-Bielack, Beate ;
Branscheid, Detlev ;
Carrle, Dorothe ;
Friedel, Godehard ;
Helmke, Knut ;
Kevric, Matthias ;
Jundt, Gernot ;
Kuehne, Thomas ;
Maas, Rainer ;
Schwarz, Rudolf ;
Zoubek, Andreas ;
Juergens, Heribert .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (04) :557-565
[7]   Tumor size and prognosis in aggressively treated osteosarcoma [J].
Bieling, P ;
Rehan, N ;
Winkler, P ;
Helmke, K ;
Maas, R ;
Fuchs, N ;
Bielack, S ;
Heise, U ;
Jurgens, H ;
Treuner, J ;
Romanowski, R ;
Exner, U ;
Kotz, R ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :848-858
[8]   Prognostic Factors After Relapse in Nonmetastatic Rhabdomyosarcoma: A Nomogram to Better Define Patients Who Can Be Salvaged With Further Therapy [J].
Chisholm, Julia C. ;
Marandet, Julien ;
Rey, Annie ;
Scopinaro, Marcelo ;
de Toledo, Jose Sanchez ;
Merks, Johannes H. M. ;
Meara, Anne O. ;
Stevens, Michael C. G. ;
Oberlin, Odile .
JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (10) :1319-1325
[9]   Differential Presentations, Clinical Courses, and Survivals of Osteosarcomas of the Proximal Humerus over Other Extremity Locations [J].
Cho, Wan Hyeong ;
Song, Won Seok ;
Jeon, Dae-Geun ;
Kong, Chang-Bae ;
Kim, Min Suk ;
Lee, Jun Ah ;
Yoo, Ji Young ;
Do Kim, Jae ;
Lee, Soo-Yong .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (03) :702-708
[10]   A review of clinical and molecular prognostic factors in osteosarcoma [J].
Clark, Jonathan C. M. ;
Dass, Crispin R. ;
Choong, Peter F. M. .
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (03) :281-297